Biotech Innovations Made in Austria: Turning Bioprocess Innovation into Industrial Reality

In this session, VALIDOGEN will share practical strategies for “robust or bust” strain and process development using Pichia pastoris, showing how genetic engineering, modular expression solutions and data-guided optimization can translate into predictable large-scale protein production. Flecks Brauhaus Technik GmbH will introduce B.R.O.M.®, a novel bioreactor scale-up approach that decouples process control and infrastructure from the vessel to enable consistent conditions from 30 to 20,000 L, reducing cost and time-to-market. BRAVE Analytics will highlight how single-particle Raman analytics can move from cutting-edge optofluidic physics into real industrial bioprocess applications, enabling deeper insight and better control of complex bioprocesses. Lanbiotic adds the perspective of translating microbiome-driven biotech innovations toward scalable, market-ready applications. Expect concrete lessons learned, technology insights, and an interactive discussion on what it takes to bridge the gap between R&D success and industrial manufacturing reality.